Doctor of Health Sciences : 2017A.T. Still University of Health Sciences － Mesa, AZ
Master of Advanced Studies : 2011University of California － San Diego, CAA Comparison of IVIG Related Adverse Events in Patients with Chronic Idiopathic
Thrombocytopenic Purpura: A head-to-head study with Gamunex [intravenous immune globulin
(human), 10% caprylate/chromatography purified] and Privigen [immune globulin intravenous
Bachelor of Arts : Pre-med, 1995Miami University － Oxford, OHPre-med
Medical Science Liaison January 2012 to CurrentNuFactor Specialty Pharmacy － Santa Fe, NM
Responsible for the scientific support of plasma-derived immunoglobulin therapies through key
opinion leader identification and management, the participation in, execution, and publication of
product-related research, and scientific representation at conferences.
Academic Accounts Director January 2010 to January 2012Walgreens Infusion Services － Santa Fe, NM
Responsible for the promotion of immunoglobulin therapy home infusion services to academic key
opinion leaders in the South Central region.
Immunology Sales Representative January 2004 to January 2010Talecris Biotherapeutics － San Diego, CA
Promoted biotechnology products for rare, chronic, and orphan diseases including
immunodeficiencies, genetic enzyme deficiencies, coagulation management, and autoimmune
Sales Consultant January 1999 to January 2003Novartis Pharmaceuticals － Phoenix, AZ
Sold a wide range of products via clinical studies and innovative promotion to cardiologists,
dermatologists, and FP/GP/IM's.
Levine, T., Katz, J., Barohn, R., Wolfe, G., Mozaffar, T., Saperstein, D., Katzin, L., Dimachkie, M., Ritt, E., Vaughan, L., Greer, M. Ig Treatment
Outcomes Assessment and Clinical Guidelines Study (the "INSIGHTS Study"): Preliminary Findings on Scope of Practice from the INSIGHTS
Database. Neurology April 8, 2014 82: P7.099.
Levine T., Katz J., Barohn R., Mozaffar T., Saperstein, D., Katzin L., Dimachkie M., Ritt E., Vaughan L., Greer M., Wolfe G.I. Immunoglobulin
treatment outcomes assessment and clinical guidelines study (INSIGHTS): preliminary findings on scope of practice in the U.S. Presented at the
7th International Immunoglobulin Conference, Interlaken, Switzerland, 4/4/14-4/5/14.
Katz, J., Levine, T., Barohn, R., Mozaffar, T., Wolfe, G., Saperstein, D., Katzin, L., Ritt, E., Vaughan, L., Greer, M. Understanding IVIg Prescribing
Habits through INSIGHTS (Immunological and Neurological Study of Immune Globulin Habits Treatments and Standards). Neurology February 14,
Katz, J., Levine, T., Barohn, R., Mozaffar, T., Wolfe, G., Saperstein, D., Katzin, L., Ritt, E., Vaughan, L., Greer, M. Immunoglobulin Treatment
Outcomes Assessment and Clinical Guidelines Study (The "INSIGHTS" Study): Preliminary Findings on Scope of Practice from the INSIGHTS
Database. 2013 Abstract Guide. Muscle Nerve October 2013, 48: 633-692. doi: 10.1002.
American Academy of Neurology
American Association of Neuromuscular & Electrodiagnostic Medicine
Society of Hematologic Oncology